FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Véronique Mosseri

Research Profile

Disorders

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Guillaume Vogin; Christophe Glorion; Sylvie Helfre; Eric Mascard; Véronique Mosseri; Odile Oberlin; Nathalie Gaspar
Local control and sequelae in localised Ewing tumours of the spine: a French retrospective study.
Gudrun Schleiermacher; F Speleman; G P Tonini; I Ambros; P Ambros; Edward F Attiyeh; G M Brodeur; Susan Cohn; M Fischer; M Haber; J Khan; W B London; John M Maris; Katherine K Matthay; Tom Monclair; Véronique Mosseri; A Nakagawara; R Noguera; A D J Pearson
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.
Julie Gachet; Julie Giroux; Véronique Girre; Youlia KIROVA; Jean-Jacques Mazeron; L Mignot; Véronique Mosseri; Bruno Pouit; Étienne Brain; Guillaume Dutertre; Marie-Christine Falcou; Paul-Henri Cottu
[Brain metastases in breast cancer. Epidemiology and natural history. The Institut Curie experience].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Véronique Mosseri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Guillaume Vogin; Christophe Glorion; Sylvie Helfre; Eric Mascard; Véronique Mosseri; Odile Oberlin; Nathalie Gaspar
Local control and sequelae in localised Ewing tumours of the spine: a French retrospective study.
European journal of cancer (Oxford, England : 1990) 2013;49(6):1314-23.
2012: Gudrun Schleiermacher; F Speleman; G P Tonini; I Ambros; P Ambros; Edward F Attiyeh; G M Brodeur; Susan Cohn; M Fischer; M Haber; J Khan; W B London; John M Maris; Katherine K Matthay; Tom Monclair; Véronique Mosseri; A Nakagawara; R Noguera; A D J Pearson
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.
British journal of cancer 2012;107(8):1418-22.
2011: Julie Gachet; Julie Giroux; Véronique Girre; Youlia KIROVA; Jean-Jacques Mazeron; L Mignot; Véronique Mosseri; Bruno Pouit; Étienne Brain; Guillaume Dutertre; Marie-Christine Falcou; Paul-Henri Cottu
[Brain metastases in breast cancer. Epidemiology and natural history. The Institut Curie experience].
Bulletin du cancer 2011;98(4):357-69.
2011: Hervé Rubie; Bruno De Bernardi; Mary Gerrard; Adela Canete; Ruth Ladenstein; Jérôme Couturier; Peter Ambros; Caroline Munzer; Andrew D J Pearson; Alberto Garaventa; Penelope Brock; Victoria Castel; Dominique Valteau-Couanet; Keith Holmes; Andrea Di Cataldo; Bénédicte Brichard; Véronique Mosseri; Catalina Marquez; Dominique Plantaz; Luca Boni; Jean Michon
Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(4):449-55.
2010: Angélique Girod; Antonio Brancati; Véronique Mosseri; Irène Kriegel; Thomas Jouffroy; José Rodriguez
Study of the length of hospital stay for free flap reconstruction of oral and pharyngeal cancer in the context of the new French casemix-based funding.
Oral oncology 2010;46(3):190-4.
2009: Angélique Girod; Françoise Nadaud; Véronique Mosseri; Thomas Jouffroy; José Rodriguez
Use of chimeric subscapular artery system free flaps for soft-tissue reconstruction of the oral cavity and oropharynx: advantages and donor-site morbidity.
Plastic and reconstructive surgery 2009;124(6):445e-6e.
2009: P Frange; Claire Alapetite; Geneviève Gaboriaud; Danièle Bours; Jean-Michel Zucker; Michel ZERAH; H Brisse; M Chevignard; Véronique Mosseri; E Bouffet; François Doz
From childhood to adulthood: long-term outcome of medulloblastoma patients. The Institut Curie experience (1980-2000).
Journal of neuro-oncology 2009;95(2):271-9.
2009: Angélique Girod; Véronique Mosseri; Thomas Jouffroy; Daniel Point; José Rodriguez
Women and squamous cell carcinomas of the oral cavity and oropharynx: is there something new?
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2009;67(9):1914-20.
2009: Isabelle Janoueix-Lerosey; Gudrun Schleiermacher; Evi Michels; Véronique Mosseri; Agnès Ribeiro; Delphine Lequin; Joëlle Vermeulen; Jérôme Couturier; Michel Peuchmaur; Alexander Valent; Dominique Plantaz; Hervé Rubie; Dominique Valteau-Couanet; Caroline Thomas; Valérie Combaret; Raphaël Rousseau; Angelika Eggert; Jean Michon; Frank Speleman; Olivier Delattre
Overall genomic pattern is a predictor of outcome in neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(7):1026-33.
2009: Susan Cohn; Andrew D J Pearson; Wendy B London; Tom Monclair; Peter F Ambros; Garrett M Brodeur; Andreas Faldum; Barbara Hero; Tomoko Iehara; David Machin; Véronique Mosseri; Thorsten Simon; Alberto Garaventa; Victoria Castel; Katherine K Matthay
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):289-97.
2008: Véronique Girre; Marie-Christine Falcou; Mathilde Gisselbrecht; Geneviève Gridel; Véronique Mosseri; Carole Bouleuc; Rollon Poinsot; Lionel Vedrine; Liliane Ollivier; Valérie Garabige; Jean-Yves Pierga; Véronique Diéras; Laurent Mignot
Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?
The journals of gerontology. Series A, Biological sciences and medical sciences 2008;63(7):724-30.
2008: Hervé Brisse; Gudrun Schleiermacher; Sabine Sarnacki; Sylvie Helfre; Pascale Philippe-Chomette; Liliane Boccon-Gibod; Michel Peuchmaur; Véronique Mosseri; Yves Aigrain; Sylvia Neuenschwander
Preoperative Wilms tumor rupture: a retrospective study of 57 patients.
Cancer 2008;113(1):202-13.
2008: Daniel Orbach; Hervé Brisse; Sylvie Helfre; Jerzy Klijanienko; Danièle Bours; Véronique Mosseri; José Rodriguez
Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects.
Pediatric blood & cancer 2008;50(4):849-53.
2007: Gudrun Schleiermacher; Jean Michon; I Huon; C Dubois d'Enghien; Jerzy Klijanienko; Hervé Brisse; Agnès Ribeiro; Véronique Mosseri; Hervé Rubie; Caroline Munzer; C Thomas; Dominique Valteau-Couanet; Anne Auvrignon; Dominique Plantaz; Olivier Delattre; Jérôme Couturier
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification.
British journal of cancer 2007;97(2):238-46.
2007: Patricia de Cremoux; Nathalie Jourdan-Da-Silva; Jérôme Couturier; Carine Tran-Perennou; Gudrun Schleiermacher; Pascale Fehlbaum; François Doz; Véronique Mosseri; Olivier Delattre; Jerzy Klijanienko; Philippe Vielh; Jean Michon
Role of chemotherapy resistance genes in outcome of neuroblastoma.
Pediatric blood & cancer 2007;48(3):311-7.
2006: Hervé Rubie; Julia Chisholm; Anne-Sophie Defachelles; Bruce Morland; Caroline Munzer; Dominique Valteau-Couanet; Véronique Mosseri; Christophe Bergeron; Clare Weston; Carole Coze; Anne Auvrignon; Latifa Djafari; Rachel Hobson; Christiane Baunin; Fiona Dickinson; Hervé Brisse; Kieran McHugh; Lorenzo Biassoni; Francesco Giammarile; Gilles Vassal
Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5259-64.
2006: J Verlooy; Véronique Mosseri; Serge Bracard; A Lellouch Tubiana; Chantal Kalifa; Fabienne Pichon; Didier Frappaz; Pascal Chastagner; Anne Pagnier; Anne-Isabelle Bertozzi; Jean-Claude Gentet; Eric Sariban; Xavier Rialland; C Edan; Danièle Bours; Michel ZERAH; C Le Gales; Claire Alapetite; François Doz
Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study.
European journal of cancer (Oxford, England : 1990) 2006;42(17):3004-14.
2006: Samuel Navarro; Gabriele Amann; Klaus Beiske; Catherine J Cullinane; Emanuele S G d'Amore; Claudio Gambini; Véronique Mosseri; Bruno De Bernardi; Jean Michon; Michel Peuchmaur
Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(4):695-9.
2006: Cécile Badoual; Stéphane Hans; José Rodriguez; Séverine Peyrard; Christophe Klein; Nour El Houda Agueznay; Véronique Mosseri; Ollivier Laccourreye; Patrick Bruneval; Wolf H Fridman; Daniel F Brasnu; Eric Tartour
Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):465-72.
2005: Giovanni Cecchetto; Véronique Mosseri; Bruno De Bernardi; Pierre Helardot; Tom Monclair; Elisa Costa; Ernst Horcher; Sylvia Neuenschwander; Paolo Tomà; Antonino Rizzo; Jean Michon; Keith Holmes
Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8483-9.
2005: V Oyharcabal-Bourden; Chantal Kalifa; Jean-Claude Gentet; Didier Frappaz; C Edan; Pascal Chastagner; Eric Sariban; Anne Pagnier; Annie Babin; Fabienne Pichon; Sylvia Neuenschwander; Matthieu Vinchon; Danièle Bours; Véronique Mosseri; C Le Gales; Marie-Magdeleine Ruchoux; Christian Carrie; François Doz
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(21):4726-34.
2004: Isabelle Aerts; Hélène Pacquement; François Doz; Véronique Mosseri; Laurence Desjardins; Xavier Sastre; Jean Michon; José Rodriguez; Pierre Schlienger; Jean-Michel Zucker; Erica Quintana
Outcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut Curie.
European journal of cancer (Oxford, England : 1990) 2004;40(10):1522-9.
2004: Isabelle Coupier; Céline Baldeyron; Alexandra Rousseau; Véronique Mosseri; Sabine Pages-Berhouet; Virginie Caux-Moncoutier; Dora Papadopoulo; Dominique Stoppa-Lyonnet
Fidelity of DNA double-strand break repair in heterozygous cell lines harbouring BRCA1 missense mutations.
Oncogene 2004;23(4):914-9.
2003: Laurent Chauveinc; X Buthaud; Marie-Christine Falcou; Véronique Mosseri; Anne de La Rochefordière; Jean-Yves Pierga; Jacques Girodet; Rémy J Salmon
Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy.
British journal of cancer 2003;89(11):2057-61.
2003: Hervé Rubie; Carole Coze; Dominique Plantaz; Caroline Munzer; Anne-Sophie Defachelles; Christophe Bergeron; C Thomas; Pascal Chastagner; Dominique Valteau-Couanet; Jean Michon; Véronique Mosseri; Olivier Hartmann
Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy.
British journal of cancer 2003;89(9):1605-9.
2003: Katherine K Matthay; Hervé Brisse; Dominique Couanet; Jérôme Couturier; Jean Bénard; Véronique Mosseri; Véronique Edeline; Jean Lumbroso; Dominique Valteau-Couanet; Jean Michon
Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.
Cancer 2003;98(1):155-65.
2002: François Doz; Sylvia Neuenschwander; E Bouffet; Jean-Claude Gentet; P Schneider; Chantal Kalifa; Françoise Mechinaud; Pascal Chastagner; Lionel de Lumley; Eric Sariban; Dominique Plantaz; Véronique Mosseri; Danièle Bours; Claire Alapetite; Jean-Michel Zucker
Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Société Française d'Oncologie Pédiatrique.
European journal of cancer (Oxford, England : 1990) 2002;38(6):815-9.
2002: Raymond S McDermott; Frédéric Beuvon; Marc Pauly; Claude Pallud; Anne Vincent-Salomon; Véronique Mosseri; Pierre Pouillart; Susy M Scholl
Tumor antigens and antigen-presenting capacity in breast cancer.
Pathobiology : journal of immunopathology, molecular and cellular biology 2002;70(6):324-32.
2002: Raymond S McDermott; Laurent Deneux; Véronique Mosseri; Jacques Védrenne; Krishna B Clough; Alain Fourquet; José Rodriguez; Jean-Marc Cosset; Xavier Sastre; Philippe Beuzeboc; Pierre Pouillart; Susy M Scholl
Circulating macrophage colony stimulating factor as a marker of tumour progression.
European cytokine network 2002;13(1):121-7.
2001: Zofia Maciorowski; Jerzy Klijanienko; Eliane Padoy; Véronique Mosseri; Alain Fourquet; Sylvie Chevillard; Adel K El-Naggar; Philippe Vielh
Comparative image and flow cytometric TUNEL analysis of fine needle samples of breast carcinoma.
Cytometry 2001;46(3):150-6.
2001: Laurent Chauveinc; Véronique Mosseri; Erica Quintana; Laurence Desjardins; Pierre Schlienger; François Doz; Bernard Dutrillaux
Osteosarcoma following retinoblastoma: age at onset and latency period.
Ophthalmic genetics 2001;22(2):77-88.
2001: E Tartour; Véronique Mosseri; T Jouffroy; Laurent Deneux; C Jaulerry; F Brunin; W H Fridman; J Rodriguez
Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer.
Lancet 2001;357(9264):1263-4.
2000: Zofia Maciorowski; Jerzy Klijanienko; Eliane Padoy; Véronique Mosseri; Véronique Diéras; Adel K El-Naggar; Sylvie Chevillard; Philippe Vielh
Differential expression of Bax and Bcl-2 in the assessment of cellular dynamics in fine-needle samples of primary breast carcinomas.
Cytometry 2000;42(5):264-9.
2000: D Zhuang; N Schenker; Jeremy Taylor; Véronique Mosseri; Bernard Dubray
Analysing the effects of anaemia on local recurrence of head and neck cancer when covariate values are missing.
Statistics in medicine 2000;19(9):1237-49.
1999: F Brunin; Véronique Mosseri; C Jaulerry; D Point; Jean-Marc Cosset; José Rodriguez
Cancer of the base of the tongue: past and future.
Head & neck 1999;21(8):751-9.
1999: Jerzy Klijanienko; Jérôme Couturier; M Galut; Adel K El-Naggar; Zofia Maciorowski; Eliane Padoy; Véronique Mosseri; Philippe Vielh
Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of HER-2/neu gene amplification in breast cancer fine-needle samples.
Cancer 1999;87(5):312-8.
1999: Eric Tartour; François Fossiez; I Joyeux; Annie Galinha; Alain Gey; Emmanuel Claret; Xavier Sastre-Garau; Jérôme Couturier; Véronique Mosseri; Virginie Vives; Jacques Banchereau; Wolf H Fridman; John Wijdenes; Serge Lebecque; Catherine Sautès-Fridman
Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.
Cancer research 1999;59(15):3698-704.
1999: Philippe Broët; Anne de La Rochefordière; Susy M Scholl; Alain Fourquet; Yann De Rycke; Pierre Pouillart; Véronique Mosseri; Bernard Asselain
Analyzing prognostic factors in breast cancer using a multistate model.
Breast cancer research and treatment 1999;54(1):83-9.
1998: Krishna B Clough; J Cuminet; Alfred Fitoussi; Claude Nos; Véronique Mosseri
Cosmetic sequelae after conservative treatment for breast cancer: classification and results of surgical correction.
Annals of plastic surgery 1998;41(5):471-81.
1998: Franck Pages; Thierry Flam; Annick Vieillefond; V Molinie; X Abeille; V Lazar; B Bressac-de Paillerets; Véronique Mosseri; Marc Zerbib; Wolf H Fridman; Bernard Debré; Nicolas Thiounn
p53 status does not predict initial clinical response to bacillus Calmette-Guerin intravesical therapy in T1 bladder tumors.
The Journal of urology 1998;159(3):1079-84.
1998: Eric Tartour; Alain Gey; Xavier Sastre-Garau; I Lombard Surin; Véronique Mosseri; Wolf H Fridman
Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas.
Journal of the National Cancer Institute 1998;90(4):287-94.
1997: Félix A Montero-Julian; H Brailly; C Sautès; I Joyeux; Thierry Dorval; Véronique Mosseri; K Yasukawa; John Wijdenes; A Adler; I Gorin; Wolf H Fridman; Eric Tartour
Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(8):1443-51.
1997: Nicolas Thiounn; Franck Pages; Thierry Flam; Eric Tartour; Véronique Mosseri; Marc Zerbib; Philippe Beuzeboc; Laurent Deneux; Wolf H Fridman; Bernard Debré
IL-6 is a survival prognostic factor in renal cell carcinoma.
Immunology letters 1997;58(2):121-4.
1997: Y Remvikos; Véronique Mosseri; Bernard Asselain; Alain Fourquet; Jean-Claude Durand; Pierre Pouillart; Henri Magdelénat
S-phase fractions of breast cancer predict overall and post-relapse survival.
European journal of cancer (Oxford, England : 1990) 1997;33(4):581-6.
1997: Eric Tartour; Laurent Deneux; Véronique Mosseri; C Jaulerry; F Brunin; D Point; Pierre Validire; Bernard Dubray; Wolf H Fridman; José Rodriguez
Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study.
Cancer 1997;79(7):1401-8.
1996: Bernard Dubray; Véronique Mosseri; F Brunin; C Jaulerry; P Poncet; José Rodriguez; J Brugère; D Point; P Giraud; Jean-Marc Cosset
Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study.
Radiology 1996;201(2):553-8.
1996: Philippe Broët; Anne de La Rochefordière; Susy M Scholl; Alain Fourquet; Véronique Mosseri; Jean-Claude Durand; Pierre Pouillart; Bernard Asselain
[Contralateral breast cancer: metastasis or second primary cancer?].
Bulletin du cancer 1996;83(10):870-6.
1996: Eric Tartour; Jean-Yves Blay; Thierry Dorval; Bernard Escudier; Véronique Mosseri; Jean-Yves Douillard; Laurent Deneux; I Gorin; Sylvie Negrier; Claire Mathiot; Pierre Pouillart; Wolf H Fridman
Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1697-703.
1996: G Schleiermacher; Olivier Delattre; Martine Peter; Véronique Mosseri; P Delonlay; Philippe Vielh; Gilles Thomas; Jean-Michel Zucker; Henri Magdelénat; Jean Michon
Clinical relevance of loss heterozygosity of the short arm of chromosome 1 in neuroblastoma: a single-institution study.
International journal of cancer. Journal international du cancer 1996;69(2):73-8.
1996: François Doz; Martine Peter; G Schleiermacher; Philippe Vielh; Pierre Validire; M Putterman; V Blanquet; Laurence Desjardins; Jean-Louis Dufier; Jean-Michel Zucker; Véronique Mosseri; Gilles Thomas; Henri Magdelénat; Olivier Delattre
N-MYC amplification, loss of heterozygosity on the short arm of chromosome 1 and DNA ploidy in retinoblastoma.
European journal of cancer (Oxford, England : 1990) 1996;32A(4):645-9.
1996: Susy M Scholl; Rosette Lidereau; Anne de La Rochefordière; C C Le-Nir; Véronique Mosseri; C Noguès; Pierre Pouillart; F R Stanley
Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study.
Breast cancer research and treatment 1996;39(3):275-83.
1996: Jean-Yves Pierga; A Leroyer; P Viehl; Véronique Mosseri; Sylvie Chevillard; Henri Magdelénat
Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer.
Breast cancer research and treatment 1996;37(1):57-64.
1996: Thierry Dorval; C Soussain; Philippe Beuzeboc; E Garcia-Giralt; Michel Jouve; Alain Livartowski; Véronique Mosseri; Thao Palangié; Susy M Scholl; Xavier Sastre; Pierre Pouillart
Ifosfamide seven-day infusion for recurrent and cisplatin refractory ovarian cancer.
The Journal of infusional chemotherapy 1996;6(1):47-9.
1995: Eric Tartour; S Latour; Claire Mathiot; Nicolas Thiounn; Véronique Mosseri; I Joyeux; C D D'Enghien; R Lee; B Debre; Wolf H Fridman
Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function.
International journal of cancer. Journal international du cancer 1995;63(2):205-12.
1995: C Jaulerry; Bernard Dubray; F Brunin; José Rodriguez; D Point; B Blaszka; Bernard Asselain; Véronique Mosseri; J Brugere; Jean-Marc Cosset
Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study.
International journal of radiation oncology, biology, physics 1995;33(2):271-9.
1995: E Saccomandi; Krishna B Clough; Véronique Mosseri; P Viehl; M Legal; Alain Fourquet; C Renolleau; Jean-Claude Durand
[Breast cancer without palpable tumor revealed by microcalcifications. Prognosis and treatment].
Presse médicale (Paris, France : 1983) 1995;24(28):1291-5.
1995: Philippe Broët; Anne de La Rochefordière; Susy M Scholl; Alain Fourquet; Véronique Mosseri; Jean-Claude Durand; Pierre Pouillart; Bernard Asselain
Contralateral breast cancer: annual incidence and risk parameters.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1578-83.
1995: Nicolas Thiounn; Claire Mathiot; Thierry Dorval; Thierry Flam; Eric Tartour; Véronique Mosseri; Marc Zerbib; Wolf H Fridman; B Debre
Lack of efficacy of low-dose subcutaneous recombinant interleukin-2 and interferon-alpha in the treatment of metastatic renal cell carcinoma.
British journal of urology 1995;75(5):586-9.
1995: François Doz; Sylvia Neuenschwander; Dominique Plantaz; B Courbon; Jean-Claude Gentet; E Bouffet; Véronique Mosseri; Jean-Pierre Vannier; Françoise Mechinaud; Laurence Desjardins
Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(4):902-9.
1995: M Maher; F Campana; Véronique Mosseri; H Dreyfus; J R Vilcoq; C Gautier; Bernard Asselain; Alain Fourquet
Breast cancer in elderly women: a retrospective analysis of combined treatment with tamoxifen and once-weekly irradiation.
International journal of radiation oncology, biology, physics 1995;31(4):783-9.
1995: Alain Fourquet; F Campana; Véronique Mosseri; R Cetingoz; S Luciani; A Labib; Bernard Asselain; J R Vilcoq
Iridium-192 versus cobalt-60 boost in 3-7 cm breast cancer treated by irradiation alone: final results of a randomized trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995;34(2):114-20.
1995: C Renolleau; M P Laroussinie; Véronique Mosseri; J Fenton; Anne de La Rochefordière; Krishna B Clough; J P Hamelin; Jean-Claude Durand
[Pelvic lymph node invasion in cancer of the uterine cervix].
Bulletin du cancer 1995;82(5):377-83.
1994: Eric Tartour; Alain Gey; Xavier Sastre-Garau; C Pannetier; Véronique Mosseri; P Kourilsky; Wolf H Fridman
Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma.
Cancer research 1994;54(23):6243-8.
1994: François Doz; F Khelfaoui; Véronique Mosseri; Pierre Validire; Erica Quintana; Jean Michon; Laurence Desjardins; Pierre Schlienger; Sylvia Neuenschwander; Philippe Vielh
The role of chemotherapy in orbital involvement of retinoblastoma. The experience of a single institution with 33 patients.
Cancer 1994;74(2):722-32.
1994: Eric Tartour; Thierry Dorval; Véronique Mosseri; Laurent Deneux; Claire Mathiot; H Brailly; F Montero; I Joyeux; Pierre Pouillart; Wolf H Fridman
Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients.
British journal of cancer 1994;69(5):911-3.
1994: Susy M Scholl; C H Bascou; Véronique Mosseri; R Olivares; Henri Magdelenat; Thierry Dorval; Thao Palangié; Pierre Validire; Pierre Pouillart; E Richard Stanley
Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer.
British journal of cancer 1994;69(2):342-6.
1994: Jean Michon; Olivier Delattre; Jean-Michel Zucker; Martine Peter; P Delonlay; S Luciani; Véronique Mosseri; Philippe Vielh; S Neuenschwander; Gilles Thomas
Prospective evaluation of Nmyc amplification and deletion of the short arm of chromosome 1 in neuroblastoma tumours: a single institution study.
Progress in clinical and biological research 1994;385():11-7.
1994: T Palangie; Véronique Mosseri; J Mihura; F Campana; Philippe Beuzeboc; Thierry Dorval; E Garcia-Giralt; Michel Jouve; Susy M Scholl; Bernard Asselain
Prognostic factors in inflammatory breast cancer and therapeutic implications.
European journal of cancer (Oxford, England : 1990) 1994;30A(7):921-7.
1993: Yurgos Remvikos; Véronique Mosseri; A Zajdela; Alain Fourquet; Jean-Claude Durand; Pierre Pouillart; Henri Magdelénat
Prognostic value of the S-phase fraction of breast cancers treated by primary radiotherapy or neoadjuvant chemotherapy.
Annals of the New York Academy of Sciences 1993;698():193-203.
1993: Susy M Scholl; Véronique Mosseri; R Tang; F Beuvon; C Palud; Rosette Lidereau; Pierre Pouillart
Expression of colony-stimulating factor-1 and its receptor (the protein product of c-fms) in invasive breast tumor cells. Induction of urokinase production via this pathway?
Annals of the New York Academy of Sciences 1993;698():131-5.
1993: Claire Mathiot; Jean-Luc Teillaud; M Elmalek; Véronique Mosseri; Liana Euller-Ziegler; Alain Daragon; B Grosbois; JL Michaux; T Facon; J F Bernard
Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma.
Journal of clinical immunology 1993;13(1):41-8.
1993: Michel Jouve; Thierry Dorval; Véronique Mosseri; T Palangie; Philippe Beuzeboc; E Garcia-Giralt; Alain Livartowski; Susy M Scholl; Pierre Pouillart
A phase II study of etoposide, cisplatin plus methotrexate in patients with advanced refractory breast cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(9):1355.
1993: Claire Mathiot; B Grosbois; Jean-Luc Teillaud; Eric Tartour; Véronique Mosseri; Liana Euller-Ziegler; Alain Daragon; JL Michaux; T Facon; J F Bernard
[Correlation between the serum level of soluble CD16 and the staging of myeloma: study of 214 serums].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1993;14(10):960.
1992: R Tang; F Beuvon; M Ojeda; Véronique Mosseri; Pierre Pouillart; Susy M Scholl
M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes?
Journal of cellular biochemistry 1992;50(4):350-6.
1992: Philippe Vielh; Henri Magdelénat; Véronique Mosseri; Yurgos Remvikos; L di Bonito
Immunocytochemical determination of estrogen and progesterone receptors on 50 fine-needle samples of breast cancer. A prospective study including biochemical correlation and DNA flow cytometric analysis.
American journal of clinical pathology 1992;97(2):254-61.
1992: C Jaulerry; José Rodriguez; F Brunin; Michel Jouve; Véronique Mosseri; D Point; Dominique Pontvert; Pierre Validire; Brigitte Zafrani; B Blaszka
Induction chemotherapy in advanced head and neck tumors: results of two randomized trials.
International journal of radiation oncology, biology, physics 1992;23(3):483-9.
1992: J Dumont; P Charpy-Validire; M Raphael; M Tulliez; V Le Doussal; J Barge; Véronique Mosseri
[Large cell lymphomas: effect of histologic groups on the prognosis. Study of 210 cases treated with the same therapeutic protocols].
Archives d'anatomie et de cytologie pathologiques 1992;40(2-3):110-5.
1992: R Klaassen; Xavier Sastre-Garau; Alain Aurias; Véronique Mosseri; Thao Palangié; M Laurent; M Forest; Bernard Tomeno; Pierre Pouillart
[Ewing's sarcoma of bone in adults: an anatomic-clinical study of 30 cases].
Bulletin du cancer 1992;79(2):161-7.
1992: F Brunin; José Rodriguez; C Jaulerry; Véronique Mosseri; Michel Jouve; D Point; Bernard Asselain; Pierre Validire; B Blaszka; Brigitte Zafrani
[Role of neoadjuvant chemotherapy in the treatment of advanced head and neck tumors. Results of two randomized therapeutical trials conducted at the Institut Curie on 208 patients].
Bulletin du cancer 1992;79(9):893-904.
1991: E Darai; Véronique Mosseri; J P Hamelin; Rémy J Salmon; I Karaitianos; P Bataini; G Mathieu; R J Vilcoq; Jean-Claude Durand
[Conservative surgery after radiotherapy with preoperative doses in the treatment of breast cancer].
Presse médicale (Paris, France : 1983) 1991;20(42):2144-8.
1991: Pierre Laurent-Puig; Sylviane Olschwang; Olivier Delattre; Pierre Validire; T Melot; Véronique Mosseri; Rémy J Salmon; Gilles Thomas
Association of Ki-ras mutation with differentiation and tumor-formation pathways in colorectal carcinoma.
International journal of cancer. Journal international du cancer 1991;49(2):220-3.
1991: J Reboul-Marty; Erica Quintana; Véronique Mosseri; Françoise Flamant; Bernard Asselain; Chantal Rodary; Jean-Michel Zucker
Prognostic factors of alveolar rhabdomyosarcoma in childhood. An International Society of Pediatric Oncology study.
Cancer 1991;68(3):493-8.
1991: J Dumont; P Charpy-Validire; Véronique Mosseri; Jean Gabarre; Coralie Belanger; F Turpin; J L Binet; François Dreyfus; A Fourquet; M Janvier
Multicentre combined chemotherapy protocol for large cell advanced non Hodgkin's lymphoma.
Hematological oncology 1991;9(4-5):197-207.
1991: C Jaulerry; José Rodriguez; F Brunin; Véronique Mosseri; Dominique Pontvert; J Brugere; J P Bataini
Results of radiation therapy in carcinoma of the base of the tongue. The Curie Institute experience with about 166 cases.
Cancer 1991;67(6):1532-8.
1990: Philippe Vielh; Sylvie Chevillard; Véronique Mosseri; B Donatini; H Magdelenat
Ki67 index and S-phase fraction in human breast carcinomas. Comparison and correlations with prognostic factors.
American journal of clinical pathology 1990;94(6):681-6.
1990: R P Tang; B Kacinski; Pierre Validire; F Beuvon; Xavier Sastre; P Benoit; A dela Rochefordière; Véronique Mosseri; Pierre Pouillart; Susy M Scholl
Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells?
Journal of cellular biochemistry 1990;44(3):189-98.
1990: Anne de La Rochefordière; Rémy J Salmon; Bernard Asselain; Véronique Mosseri; Jacques Girodet; Jean-Claude Durand; A Labib; J Fenton; G Mathieu
[Local recurrence of rectal cancers. Multidimensional analysis by anatomoclinical factors and role of irradiation].
Gastroentérologie clinique et biologique 1990;14(8-9):619-25.
1989: Brigitte Zafrani; Philippe Vielh; Alain Fourquet; Véronique Mosseri; Jean-Claude Durand; R J Salmon; J R Vilcoq
Conservative treatment of early breast cancer: prognostic value of the ductal in situ component and other pathological variables on local control and survival. Long-term results.
European journal of cancer & clinical oncology 1989;25(11):1645-50.
1989: Alain Fourquet; F Campana; Brigitte Zafrani; Véronique Mosseri; Philippe Vielh; Jean-Claude Durand; J R Vilcoq
Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up.
International journal of radiation oncology, biology, physics 1989;17(4):719-25.
1989: Michel Jouve; T Palangie; L Belli; Thierry Dorval; E Garcia-Giralt; Philippe Beuzeboc; Susy M Scholl; Véronique Mosseri; Alain Livartowski; J Vedrenne
[Metastatic breast cancer. Chemotherapy with adriamycin, vindesine, cyclophosphamide and 5 FU. Value of continuous 5 FU perfusion. Results of controlled trials].
Bulletin du cancer 1989;76(6):643-52.
1989: F Brunin; José Rodriguez; C Jaulerry; Michel Jouve; Dominique Pontvert; D Point; Véronique Mosseri; P Pouillart; Bernard Asselain; J Brugere
Induction chemotherapy in advanced head and neck cancer. Preliminary results of a randomized study.
Acta oncologica (Stockholm, Sweden) 1989;28(1):61-5.
1988: G Pennehouat; Véronique Mosseri; Jean-Claude Durand; J P Hamelin; Bernard Asselain; J P Pilleron; Rémy J Salmon
[Lymphoceles and peritonization following lymphadenectomy for cancer of the uterus].
Journal de gynécologie, obstétrique et biologie de la reproduction 1988;17(3):373-8.
1988: J M Nadal; Michel Jouve; Véronique Mosseri; Bernard Asselain; Pierre Pouillart
[Metastatic cancer of the breast treated by polychemotherapy: a new prognostic approach].
Bulletin du cancer 1988;75(8):757-69.